Dow Jones

42,840.26

1.18%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

NVTA

Invitae (NVTA)

Invitae Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:NVTA

1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
28/06/2024	20:43	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
30/01/2024	06:00	PR Newswire (US)	Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics	NYSE:NVTA	Invitae Corporation
29/01/2024	15:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:NVTA	Invitae Corporation
24/01/2024	15:34	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NYSE:NVTA	Invitae Corporation
22/01/2024	06:00	PR Newswire (US)	Invitae Completes Sale of Reproductive Health Assets to Natera	NYSE:NVTA	Invitae Corporation
21/12/2023	20:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
13/12/2023	15:07	PR Newswire (US)	Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts	NYSE:NVTA	Invitae Corporation
14/11/2023	18:55	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
08/11/2023	15:36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:NVTA	Invitae Corporation
08/11/2023	15:01	PR Newswire (US)	Invitae Reports Third Quarter 2023 Financial Results	NYSE:NVTA	Invitae Corporation
06/11/2023	15:00	PR Newswire (US)	Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships	NYSE:NVTA	Invitae Corporation
01/11/2023	05:59	PR Newswire (US)	Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023	NYSE:NVTA	Invitae Corporation
25/10/2023	10:00	PR Newswire (US)	Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results	NYSE:NVTA	Invitae Corporation
19/10/2023	15:30	PR Newswire (US)	Invitae Appoints Dr. David Sholehvar as Chief Operating Officer	NYSE:NVTA	Invitae Corporation
12/10/2023	15:15	PR Newswire (US)	Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast Cancer	NYSE:NVTA	Invitae Corporation
10/10/2023	15:30	PR Newswire (US)	Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics	NYSE:NVTA	Invitae Corporation
03/10/2023	11:07	PR Newswire (US)	Invitae's Common Hereditary Cancers Panel Receives FDA Market Authorization	NYSE:NVTA	Invitae Corporation
29/09/2023	19:00	Dow Jones News	FDA Gives Marketing Authorization to Invitae Test for Cancer Genes	NYSE:NVTA	Invitae Corporation
25/09/2023	15:30	PR Newswire (US)	Invitae Announces Appointment of Finance Veteran Ana Schrank as CFO	NYSE:NVTA	Invitae Corporation
22/09/2023	15:30	PR Newswire (US)	Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard	NYSE:NVTA	Invitae Corporation
28/08/2023	15:02	PR Newswire (US)	Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer	NYSE:NVTA	Invitae Corporation
15/08/2023	06:30	PR Newswire (US)	Clinical Trial Results Support Genetic Testing of All Patients with Prostate Cancer	NYSE:NVTA	Invitae Corporation
14/08/2023	15:02	PR Newswire (US)	Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFO	NYSE:NVTA	Invitae Corporation
10/08/2023	15:03	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:NVTA	Invitae Corporation
09/08/2023	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NYSE:NVTA	Invitae Corporation
09/08/2023	08:22	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NYSE:NVTA	Invitae Corporation
08/08/2023	15:01	PR Newswire (US)	Invitae Reports Second Quarter 2023 Financial Results	NYSE:NVTA	Invitae Corporation
26/07/2023	15:01	PR Newswire (US)	Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023	NYSE:NVTA	Invitae Corporation
03/07/2023	13:52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:NVTA	Invitae Corporation
15/06/2023	15:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:NVTA	Invitae Corporation